Vasomotor Symptoms: More Than Temporary Menopausal Symptoms

Overview

Journal J Menopausal Med

Date 2021 Jan 10

PMID 33423402

Citations 3

Authors

Ki Jin Ryu

Hyuntae Park

Jin Seol Park

Yeon Woo Lee

Soo Young Kim

Hayun Kim

Youngmi Jeong

Yong Jin Kim

Kyong Wook Yi

Jung Ho Shin

Jun Young Hur

Tak Kim

Affiliations

Soon will be listed here.

Abstract

Vasomotor symptoms (VMS), such as hot flashes and night sweating, are classic menopausal symptoms experienced by a majority of perimenopausal and postmenopausal women. VMS have received a great deal of attention due to their relationship with cardiometabolic risk. Further, accumulating evidence indicates that VMS are associated with an increased risk of several chronic diseases, including metabolic syndrome, type 2 diabetes mellitus, nonalcoholic fatty liver diseases, and osteoporosis in perimenopausal and postmenopausal women. These findings suggest VMS as biomarkers of impaired cardiometabolic conditions rather than just temporary symptoms in menopausal women, warranting further studies to confirm the casual relationship of VMS with these diseases and the exact underlying mechanism in this context.

Citing Articles

Glutamatergic and GABAergic neurons in the preoptic area of the hypothalamus play key roles in menopausal hot flashes.

Sun Y, Wang H, Wang W, Lu J, Zhang J, Luo X Front Aging Neurosci. 2022; 14:993955.

PMID: 36313017 PMC: 9614233. DOI: 10.3389/fnagi.2022.993955.

Sex Differences in Biological Systems and the Conundrum of Menopause: Potential Commonalities in Post-Menopausal Disease Mechanisms.

Hart D Int J Mol Sci. 2022; 23(8).

PMID: 35456937 PMC: 9026302. DOI: 10.3390/ijms23084119.

Menopausal symptoms and risk of heart failure: a retrospective analysis from Taiwan National Health Insurance Database.

Huang C, Kor C, Lian I, Chang C ESC Heart Fail. 2021; 8(4):3295-3307.

PMID: 34151548 PMC: 8318496. DOI: 10.1002/ehf2.13480.

References

Prague J, Roberts R, Comninos A, Clarke S, Jayasena C, Nash Z . Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389(10081):1809-1820. PMC: 5439024. DOI: 10.1016/S0140-6736(17)30823-1. View

Ryu K, Park H, Kwon D, Yang K, Kim Y, Yi K . Vasomotor symptoms and metabolic syndrome in Korean postmenopausal women. Menopause. 2015; 22(11):1239-45. DOI: 10.1097/GME.0000000000000461. View

Thurston R, Chang Y, Mancuso P, Matthews K . Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation. Fertil Steril. 2013; 100(3):793-800. PMC: 3759568. DOI: 10.1016/j.fertnstert.2013.05.005. View

Huang A, Grady D, Blackwell T, Bauer D . Hot flushes, bone mineral density, and fractures in older postmenopausal women. Obstet Gynecol. 2007; 109(4):841-7. DOI: 10.1097/01.AOG.0000258297.02413.6e. View

Luheshi G, Gardner J, Rushforth D, Loudon A, Rothwell N . Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A. 1999; 96(12):7047-52. PMC: 22051. DOI: 10.1073/pnas.96.12.7047. View

Sahakyan K, Somers V, Rodriguez-Escudero J, Hodge D, Carter R, Sochor O . Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med. 2015; 163(11):827-35. PMC: 4995595. DOI: 10.7326/M14-2525. View

Thurston R, El Khoudary S, Tepper P, Jackson E, Joffe H, Chen H . Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation. Stroke. 2015; 47(1):12-7. PMC: 4696910. DOI: 10.1161/STROKEAHA.115.010600. View

Gast G, Grobbee D, Pop V, Keyzer J, Wijnands-van Gent C, Samsioe G . Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008; 51(6):1492-8. DOI: 10.1161/HYPERTENSIONAHA.107.106526. View

Thurston R, El Khoudary S, Sutton-Tyrrell K, Crandall C, Gold E, Sternfeld B . Vasomotor symptoms and lipid profiles in women transitioning through menopause. Obstet Gynecol. 2012; 119(4):753-61. PMC: 3343636. DOI: 10.1097/AOG.0b013e31824a09ec. View

10.

Thurston R, Sutton-Tyrrell K, Everson-Rose S, Hess R, Powell L, Matthews K . Hot flashes and carotid intima media thickness among midlife women. Menopause. 2011; 18(4):352-8. PMC: 3116932. DOI: 10.1097/gme.0b013e3181fa27fd. View

11.

Kwon D, Lee J, Ryu K, Park H, Kim T . Vasomotor symptoms and the homeostatic model assessment of insulin-resistance in Korean postmenopausal women. Obstet Gynecol Sci. 2016; 59(1):45-9. PMC: 4742475. DOI: 10.5468/ogs.2016.59.1.45. View

12.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

13.

Muka T, Oliver-Williams C, Kunutsor S, Laven J, Fauser B, Chowdhury R . Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016; 1(7):767-776. DOI: 10.1001/jamacardio.2016.2415. View

14.

Stuenkel C, Davis S, Gompel A, Lumsden M, Murad M, Pinkerton J . Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(11):3975-4011. DOI: 10.1210/jc.2015-2236. View

15.

Ryu K, Park H, Kim Y, Yi K, Shin J, Hur J . Moderate to severe vasomotor symptoms are risk factors for non-alcoholic fatty liver disease in postmenopausal women. Maturitas. 2018; 117:22-28. DOI: 10.1016/j.maturitas.2018.08.011. View

16.

Levin V, Jiang X, Kagan R . Estrogen therapy for osteoporosis in the modern era. Osteoporos Int. 2018; 29(5):1049-1055. DOI: 10.1007/s00198-018-4414-z. View

17.

. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; 24(7):728-753. DOI: 10.1097/GME.0000000000000921. View

18.

Vongpatanasin W . Autonomic regulation of blood pressure in menopause. Semin Reprod Med. 2009; 27(4):338-45. DOI: 10.1055/s-0029-1225262. View

19.

Gray K, Katon J, LeBlanc E, Woods N, Bastian L, Reiber G . Vasomotor symptom characteristics: are they risk factors for incident diabetes?. Menopause. 2017; 25(5):520-530. PMC: 5898980. DOI: 10.1097/GME.0000000000001033. View

20.

Cobbina E, Akhlaghi F . Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017; 49(2):197-211. PMC: 5576152. DOI: 10.1080/03602532.2017.1293683. View